A Simultaneous Treatment Regimen Compared to a Sequential Treatment Regimen With Ingenol Mebutate Gel 0.015% and 0.05% of Two Areas With Actinic Keratosis on Face/Scalp and Trunk/Extremities

Clinical trial NCT01787383 · COMPLETED

Trial details

NCT number: NCT01787383
Sponsor: LEO Pharma
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Actinic Keratosis

Start date: 2013-02-01
Primary completion: 2014-01-01
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.